310 related articles for article (PubMed ID: 500134)
1. An immunogenetic basis for the tissue involvement in Behçet's syndrome.
Lehner T; Batchelor JR; Challacombe SJ; Kennedy L
Immunology; 1979 Aug; 37(4):895-900. PubMed ID: 500134
[TBL] [Abstract][Full Text] [Related]
2. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.
Levinsky RJ; Lehner T
Clin Exp Immunol; 1978 May; 32(2):193-8. PubMed ID: 668196
[TBL] [Abstract][Full Text] [Related]
3. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.
Lehner T; Welsh KI; Batchelor JR
Immunology; 1982 Dec; 47(4):581-7. PubMed ID: 6958639
[TBL] [Abstract][Full Text] [Related]
4. Acute phase proteins and C9 in patients with Behcet's syndrome and aphthous ulcers.
Adinolfi M; Lehner T
Clin Exp Immunol; 1976 Jul; 25(1):36-9. PubMed ID: 1086750
[TBL] [Abstract][Full Text] [Related]
5. [HLA typing in patients of German origin with recurrent benign aphthosis and Behçet's disease].
Djawari D; Lang B; Hornstein OP
Z Hautkr; 1984 Aug; 59(15):1005-9. PubMed ID: 6485449
[TBL] [Abstract][Full Text] [Related]
6. The association of HLA-B5 antigen with specific manifestations of Behçet's disease.
Azizleri G; Aksungur VL; Sarica R; Akyol E; Ovül C
Dermatology; 1994; 188(4):293-5. PubMed ID: 8193403
[TBL] [Abstract][Full Text] [Related]
7. [The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients].
Zouboulis CC; Büttner P; Djawari D; Kirch W; Keitel W; Garbe C; von Keyserlingk-Eberius HJ; Orfanos CE
Hautarzt; 1993 Feb; 44(2):81-5. PubMed ID: 8449698
[TBL] [Abstract][Full Text] [Related]
8. The association between HLA B5 and ocular involvement in Behçet's disease in southern Turkey.
Soylu M; Ersöz TR; Erken E
Acta Ophthalmol (Copenh); 1992 Dec; 70(6):786-9. PubMed ID: 1488888
[TBL] [Abstract][Full Text] [Related]
9. HLA antigens in a family with Behçet's syndrome.
Fallingborg J; Ambrosius Christensen L; Grunnet N
Acta Med Scand; 1986; 220(4):375-8. PubMed ID: 3799242
[TBL] [Abstract][Full Text] [Related]
10. Behçet's disease: lack of correlation of clinical manifestations with HLA antigens.
Müftüoğlu AU; Yazici H; Yurdakul S; Pazarli H; Ozyazgan Y; Tüzün Y; Altaç M; Yalçin B
Tissue Antigens; 1981 Feb; 17(2):226-30. PubMed ID: 7233417
[TBL] [Abstract][Full Text] [Related]
11. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
[TBL] [Abstract][Full Text] [Related]
12. The histocompatibility antigens in patients with Behçet's disease.
Haim S; Gideoni O; Barzilai A
Acta Derm Venereol; 1977; 57(3):243-5. PubMed ID: 71830
[TBL] [Abstract][Full Text] [Related]
13. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
[TBL] [Abstract][Full Text] [Related]
14. Behçet's disease.
Wong RC; Ellis CN; Diaz LA
Int J Dermatol; 1984; 23(1):25-32. PubMed ID: 6373632
[TBL] [Abstract][Full Text] [Related]
15. Behçet's syndrome in Iranian Azari people.
Shahneh FZ; Babaloo Z; Baradaran B; Hamzavi F; Bayazi B; Bandehagh A
Pak J Biol Sci; 2012 Nov; 15(21):1045-7. PubMed ID: 24163948
[TBL] [Abstract][Full Text] [Related]
16. [Clinical aspects of Behcet's syndrome].
Grabski J; Grabski J
Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):520-2. PubMed ID: 2287569
[TBL] [Abstract][Full Text] [Related]
17. Familial Behçet's disease.
Akpolat T; Koç Y; Yeniay I; Akpek G; Güllü I; Kansu E; Kiraz S; Ersoy F; Batman F; Kansu T
Eur J Med; 1992 Nov; 1(7):391-5. PubMed ID: 1341477
[TBL] [Abstract][Full Text] [Related]
18. Association of Behçet's syndrome with HLA-B5 in the Mexican mestizo population.
Lavalle C; Alarcon-Segovia D; Del Giudice-Knipping JA; Fraga A
J Rheumatol; 1981; 8(2):325-7. PubMed ID: 7230164
[TBL] [Abstract][Full Text] [Related]
19. [Behçet's disease. II. Etiopathogenetic and therapeutic aspects. Personal observations].
Lovisetto P; Monteverde A; Cargnino M; Cadario G; Biarese V; Marchi L; Catania E
Minerva Med; 1984 Oct; 75(39):2263-82. PubMed ID: 6334250
[TBL] [Abstract][Full Text] [Related]
20. Immune complexes in Behçet's syndrome and recurrent oral ulceration.
Williams BD; Lehner T
Br Med J; 1977 May; 1(6073):1387-9. PubMed ID: 324574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
